PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
2.800
+0.010 (0.36%)
At close: May 30, 2025, 4:00 PM
2.980
+0.180 (6.43%)
After-hours: May 30, 2025, 5:45 PM EDT
PolyPid Market Cap
PolyPid has a market cap or net worth of $28.53 million as of May 30, 2025. Its market cap has increased by 30.52% in one year.
Market Cap
28.53M
Enterprise Value
29.32M
1-Year Change
30.52%
Ranking
Category
Stock Price
$2.80
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $82.43M to $28.53M, a decrease of -65.38%. That is a compound annual growth rate of -19.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 28.53M | 37.96% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | 183.09M | 122.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |